US FDA Plans More Sentinel Growth, But Industry Questions Paying With User Fees

The Sentinel 3.0 plan would enhance FDA drug safety surveillance. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from United States